Skip to content
PICO Portalanswers from OpenAlex

Giant Cell Tumors of the Foot and Ankle Bones: High Recurrence Rates After Surgical Treatment

PaperCitations, authors & open-access status

Giant Cell Tumors of the Foot and Ankle Bones: High Recurrence Rates After Surgical Treatment is a paper indexed in PICO Portal from OpenAlex.

How many citations does Giant Cell Tumors of the Foot and Ankle Bones: High Recurrence Rates After Surgical Treatment have?

PICO Portalcitation count

Giant Cell Tumors of the Foot and Ankle Bones: High Recurrence Rates After Surgical Treatment has 28 citations in the OpenAlex counts PICO Portal stores.

When was Giant Cell Tumors of the Foot and Ankle Bones: High Recurrence Rates After Surgical Treatment published?

PICO Portalyear

Giant Cell Tumors of the Foot and Ankle Bones: High Recurrence Rates After Surgical Treatment has 2014 year in the PICO Portal index.

What is the open-access status of Giant Cell Tumors of the Foot and Ankle Bones: High Recurrence Rates After Surgical Treatment?

PICO Portaloa status

Giant Cell Tumors of the Foot and Ankle Bones: High Recurrence Rates After Surgical Treatment has closed oa status in the PICO Portal index.

What is the DOI of Giant Cell Tumors of the Foot and Ankle Bones: High Recurrence Rates After Surgical Treatment?

PICO Portaldoi

The DOI for Giant Cell Tumors of the Foot and Ankle Bones: High Recurrence Rates After Surgical Treatment is on the source record.

What is the PMID of Giant Cell Tumors of the Foot and Ankle Bones: High Recurrence Rates After Surgical Treatment?

PICO Portalpmid

The PMID for Giant Cell Tumors of the Foot and Ankle Bones: High Recurrence Rates After Surgical Treatment is on the source record.

What is the OpenAlex record for Giant Cell Tumors of the Foot and Ankle Bones: High Recurrence Rates After Surgical Treatment?

PICO Portalopenalex

The OpenAlex for Giant Cell Tumors of the Foot and Ankle Bones: High Recurrence Rates After Surgical Treatment is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial